Skip to main content

Table 1 Patient demographics and disease characteristics

From: Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-up

 

CCRT group (n = 90)

 

NACT group (n = 38)

 

P-value

Characteristics

No.

%

No.

%

 

Age, years

    

0.95

 Range

15.7 - 81.5

 

22.9 - 73.0

  

 Median

48.2

 

48.2

  

 Mean

47.9

 

47.8

  

Gender

    

0.347

 Male

73

81.1

28

73.7

 

 Female

17

18.9

10

26.3

 

WHO Classification

    

0.941

 Type I

4

4.4

2

5.3

 

 Type II

31

34.4

12

31.6

 

 Type III

55

61.1

24

63.2

 

T stage

    

0.200

 T1 to T2

56

62.2

19

50

 

 T3 to T4

34

37.8

19

50

 

N stage

    

0.029

 N0 to N1

29

32.2

5

13.2

 

 N2 to N3

61

67.8

33

86.8

 

Overall Stage

    

0.002

 IIB-III

66

73.3

17

44.8

 

 IVA-IVB

24

26.7

21

55.2

 
  1. CCRT, concurrent chemoradiotherapy; NACT, neoadjuvant chemotherapy followed by radiotherapy; WHO, World Health Organization.